Wolverine Trading
CRBP icon

Wolverine Trading’s Corbus Pharmaceuticals CRBP Stock Holding History

Wolverine Trading’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-613
Closed -$5.92K – 4652
2022
Q1 		$9K Hold
613
– – ﹤0.01% 5299
2021
Q4 		$11K Sell
613
-314
-34% -$8.51K ﹤0.01% 5538
2021
Q3 		$28K Buy
+927
New +$36.6K ﹤0.01% 6105
2021
Q2 		– Sell
-796
Closed -$44.2K – 6109
2021
Q1 		$44K Buy
+796
New +$52.3K ﹤0.01% 5674
2020
Q4 		– Sell
-523
Closed -$19.6K – 4881
2020
Q3 		$31K Sell
523
-293
-36% -$53.1K ﹤0.01% 4344
2020
Q2 		$194K Buy
816
+39
+5% +$7.88K ﹤0.01% 3849
2020
Q1 		$128K Buy
777
+225
+41% +$38K ﹤0.01% 3910
2019
Q4 		$89K Buy
552
+91
+20% +$13.4K ﹤0.01% 4317
2019
Q3 		$69K Sell
461
-290
-39% -$50.5K ﹤0.01% 3966
2019
Q2 		$156K Buy
751
+84
+13% +$18K ﹤0.01% 3841
2019
Q1 		$139K Sell
667
-473
-41% -$104K ﹤0.01% 4020
2018
Q4 		$201K Buy
+1,140
New +$228K ﹤0.01% 3692
2018
Q1 		– Sell
-693
Closed -$156K – 5181
2017
Q4 		$148K Buy
+693
New +$148K ﹤0.01% 4311
2017
Q3 		– Sell
-505
Closed -$95K – 4489
2017
Q2 		$95K Buy
+505
New +$99K ﹤0.01% 3909

Other funds holding CRBP

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wolverine Trading's CRBP Position: Q2 2022 in Review

Wolverine Trading sold out of Corbus Pharmaceuticals (CRBP) in Q2 2022, closing a stake of 613 shares — an estimated $5.92K sold.

Wolverine Trading first reported a position in CRBP in Q2 2017 and held it in 14 quarters. The position peaked at $201K in Q4 2018. 70 funds tracked by Wall St. Rank hold CRBP as of Q2 2022.

  • Wolverine Trading reported no remaining Corbus Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Wolverine Trading sold 613 Corbus Pharmaceuticals shares in Q2 2022, an estimated $5.92K.
  • Wolverine Trading first reported a position in Corbus Pharmaceuticals in Q2 2017 and held it in 14 quarters.
  • Wolverine Trading's Corbus Pharmaceuticals position peaked at $201K in Q4 2018.
  • 70 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2022.

Based on Wolverine Trading's 13F filing for Q2 2022, filed 15 Aug 2022.